Literature DB >> 12111848

Establishment and characterization of spontaneously immortalized Schwann cells from murine model of globoid cell leukodystrophy (twitcher).

Jin-Song Shen1, Kazuhiko Watabe, Xing-Li Meng, Hiroyuki Ida, Toya Ohashi, Yoshikatsu Eto.   

Abstract

The twitcher mouse is a murine model of human globoid cell leukodystrophy (GLD; Krabbe disease) caused by a genetic defect in the activity of galactosylceramidase (GALC). An accumulation of cytotoxic metabolite, galactosylsphingosine (psychosine), in myelin forming cells (oligodendrocytes and Schwann cells) of the twitcher mouse as well as patients with GLD has been suggested to cause dysfunction of these cells and subsequent demyelination in the central and peripheral nervous system. To investigate further the cellular pathomechanism of GLD, we established spontaneously immortalized Schwann cell lines from the twitcher mouse. Long-term cultures of Schwann cells derived from dorsal root ganglia and consecutive peripheral nerves of 3-week-old twitcher mice were maintained for 6 months, and spontaneously developed colonies were expanded further and characterized. One of the cell lines, designated TwS1, showed distinct Schwann cell phenotypes, was passaged twice a week and maintained for over 10 months without phenotypic alterations. The TwS1 cells had a nonsense mutation in the GALC genome, and showed markedly reduced GALC activity and elevated psychosine levels. Ultrastructurally, varieties of cytoplasmic inclusions were demonstrated in TwS1 cells. When TwS1 cells were infected with a retrovirus vector encoding GALC, GALC activity was markedly increased and psychosine levels were significantly decreased. These immortalized Schwann cells can be useful in studies on the nervous system lesions in GLD. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111848     DOI: 10.1002/jnr.10247

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy.

Authors:  Adarsh S Reddy; Joong H Kim; Jacqueline A Hawkins-Salsbury; Shannon L Macauley; Elisabeth T Tracy; Carole A Vogler; Xialin Han; Sheng-Kwei Song; David F Wozniak; Stephen C Fowler; Robyn S Klein; Mark S Sands
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

2.  Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.

Authors:  Jameson J Ribbens; Ann B Moser; Walter C Hubbard; Ernesto R Bongarzone; Gustavo H B Maegawa
Journal:  Mol Genet Metab       Date:  2013-09-21       Impact factor: 4.797

Review 3.  Experimental therapies in the murine model of globoid cell leukodystrophy.

Authors:  Yedda Li; Mark S Sands
Journal:  Pediatr Neurol       Date:  2014-08-08       Impact factor: 3.372

Review 4.  Immortalized adult rodent Schwann cells as in vitro models to study diabetic neuropathy.

Authors:  Kazunori Sango; Hiroko Yanagisawa; Shizuka Takaku; Emiko Kawakami; Kazuhiko Watabe
Journal:  Exp Diabetes Res       Date:  2011-06-13

5.  Transplantation of mouse embryonic stem cell-derived oligodendrocytes in the murine model of globoid cell leukodystrophy.

Authors:  Xiao Ling Kuai; Run Zhou Ni; Guo Xiong Zhou; Zheng Biao Mao; Jian Feng Zhang; Nan Yi; Zhao Xiu Liu; Nan Shao; Wen Kai Ni; Zhi Wei Wang
Journal:  Stem Cell Res Ther       Date:  2015-03-14       Impact factor: 6.832

6.  HIV Tat Domain Improves Cross-correction of Human Galactocerebrosidase in a Gene- and Flanking Sequence-dependent Manner.

Authors:  Xing-Li Meng; Yoshikatsu Eto; Raphael Schiffmann; Jin-Song Shen
Journal:  Mol Ther Nucleic Acids       Date:  2013-10-22       Impact factor: 10.183

Review 7.  Glial cell lines: an overview.

Authors:  George H De Vries; Anne I Boullerne
Journal:  Neurochem Res       Date:  2010-12-03       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.